📰 Immune Sciences News
Page 9 - Immune Sciences News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Immune Sciences. Real-time updates on events, politics, business and more.
October 30, 2023
Alpine Immune Sciences, Inc. , a leading clinical-stage immunotherapy company focused on developing innovative treatments for autoimmune and inflammatory diseases, announced the Company will present...
October 13, 2023
-- The Company will host an investor event following the presentation after the close of market on Thursday, November 2nd -- ...
October 9, 2023
Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Free Report)’s stock price fell 6.6% during trading on Monday . The company traded as low as $11.38 and last traded at $11.38. 132,540 shares changed hands during trading, a decline of 22% from the average session volume of 169,821 shares. The stock had previously closed at $12.19. […]
October 5, 2023
ALPN | Complete Alpine Immune Sciences Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
September 18, 2023
STATEMENT OF EXECUTIVE COMPENSATION This Statement of Executive Compensation is filed by ImmunoPrecise Antibodies Ltd. pursuant to Section 11.6 of National...
September 15, 2023
Alpine Immune Sciences (NASDAQ:ALPN – Free Report) had its price objective boosted by Oppenheimer from $14.00 to $22.00 in a research report released on Monday, MarketBeat reports. Oppenheimer currently has an outperform rating on the biotechnology company’s stock. Several other research firms have also issued reports on ALPN. HC Wainwright restated a buy rating and […]
September 14, 2023
Alpine Immune Sciences (NASDAQ:ALPN – Free Report) had its target price lifted by Oppenheimer from $14.00 to $22.00 in a report issued on Monday, MarketBeat.com reports. They currently have an outperform rating on the biotechnology company’s stock. Other research analysts also recently issued research reports about the company. Wedbush reiterated an outperform rating and issued […]
September 14, 2023
Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Free Report)’s stock price was down 4.2% during mid-day trading on Tuesday . The company traded as low as $12.27 and last traded at $12.31. Approximately 16,561 shares were traded during trading, a decline of 89% from the average daily volume of 148,825 shares. The stock had previously […]
September 5, 2023
SEATTLE--(BUSINESS WIRE)--Sep 5, 2023--